Related Experiment Videos
Spatial and temporal analysis of the Drosophila FMRFamide neuropeptide gene product SDNFMRFamide: evidence for a
R Nichols1, J B McCormick, I A Lim
1Department of Biological Chemistry, University of Michigan, Ann Arbor 48109-1048, USA.
Abstract:
The expression of SDNFMRFamide, one of five different FMRFamide-containing peptides encoded by the Drosophila melanogaster FMRFamide gene, has been determined. To study expression, we generated antisera to the N-terminus of SDNFMRFamide to avoid crossreactivity with FMRFamide-containing peptides. The antisera were purified and the specificity characterized. SDNFMRFamide immunoreactive material is present in the central nervous system throughout development. Immunoreactivity is first observed in embryonic neural tissue in a cluster of cells in the subesophageal ganglion and immunoreactive fibers projecting from these cells to the brain and ventral ganglion. This pattern of expression is also observed in neural tissue dissected from larva, pupa, and adult. Double-labelling experiments indicate that cells recognized by SDNFM-antisera are also stained with FMRFamide antisera. Based on position, SDNFMRFamide immunoreactive material is expressed in a limited number of cells that contain the FMRFamide polypeptide precursor. This finding suggests that the Drosophila FMRFamide precursor undergoes differential post-translational processing.
Insights
Researchers studied the expression of a specific peptide, SDNFMRFamide, in fruit flies. They found this peptide is present in the central nervous system throughout development, suggesting complex processing of its precursor.
Area of Science:
- Neuroscience
- Developmental Biology
- Molecular Biology
Background:
- The FMRFamide gene in Drosophila melanogaster encodes multiple FMRFamide-like peptides.
- Understanding the expression patterns of these peptides is crucial for deciphering their physiological roles.
Purpose of the Study:
- To determine the expression pattern of SDNFMRFamide, a specific FMRFamide-containing peptide, within the Drosophila melanogaster central nervous system.
- To investigate the developmental expression of SDNFMRFamide and its relationship with the FMRFamide precursor.
Main Methods:
- Generation and purification of specific antisera targeting the N-terminus of SDNFMRFamide to ensure specificity.
- Characterization of antisera specificity to avoid cross-reactivity with other FMRFamide peptides.
- Immunohistochemical analysis of embryonic, larval, pupal, and adult Drosophila melanogaster neural tissues.
- Double-labeling experiments to co-localize SDNFMRFamide immunoreactivity with FMRFamide precursor expression.
Main Results:
- SDNFMRFamide immunoreactive material is consistently detected in the central nervous system across all developmental stages.
- Early embryonic expression is observed in a specific cluster of cells in the subesophageal ganglion with projections to the brain and ventral ganglion.
- Double-labeling confirms that SDNFMRFamide-expressing cells also contain the FMRFamide polypeptide precursor.
- The spatial expression pattern of SDNFMRFamide is conserved from embryonic development through adulthood.
Conclusions:
- SDNFMRFamide is expressed in a distinct subset of neurons within the Drosophila central nervous system throughout its life cycle.
- The co-expression of SDNFMRFamide and its precursor in specific cells suggests differential post-translational processing of the FMRFamide precursor.
- This study provides insights into the neurochemical organization and developmental regulation of FMRFamide-related peptides in Drosophila.